Researchers use human tissue models to investigate mechanism of action in a human-relevant in vitro setting.

A fit-for-purpose human tissue model may prioritise compound efficacy over anatomical completeness.

Benchmarking combination therapy against primary tissue improves confidence in a human tissue model.

Human tissue organoid and chip models can be used to study target validation.

Disease-relevant perturbations can be introduced to test how human tissue models respond through compound efficacy.

Researchers use human tissue models to investigate therapeutic window in a human-relevant in vitro setting.

Human tissue organoid and chip models can be used to study dose response.

In human tissue models, mechanism of action can be measured alongside cell morphology and viability.

Compound efficacy is one reason human tissue organoids or chips are useful beyond conventional monolayer culture.

Disease-relevant perturbations can be introduced to test how human tissue models respond through mechanism of action.

A fit-for-purpose human tissue model may prioritise mechanism of action over anatomical completeness.

A fit-for-purpose human tissue model may prioritise combination therapy over anatomical completeness.

Human tissue organoid and chip models can be used to study mechanism of action.

Disease-relevant perturbations can be introduced to test how human tissue models respond through combination therapy.

Benchmarking therapeutic window against primary tissue improves confidence in a human tissue model.

Human tissue organoid and chip models can be used to study combination therapy.

Donor-derived human tissue models can reveal person-to-person differences in mechanism of action.

Human tissue organoid and chip models can be used to study compound efficacy.

Biomarker discovery is one reason human tissue organoids or chips are useful beyond conventional monolayer culture.

In human tissue models, dose response can be measured alongside cell morphology and viability.

Time-course measurements can show whether changes in biomarker discovery are transient or sustained in human tissue models.

In human tissue models, compound efficacy can be measured alongside cell morphology and viability.

Human tissue organoid and chip models can be used to study therapeutic window.

Benchmarking compound efficacy against primary tissue improves confidence in a human tissue model.

Researchers use human tissue models to investigate target validation in a human-relevant in vitro setting.

Adding flow, co-culture or matrix cues can change how a human tissue model reproduces target validation.

A fit-for-purpose human tissue model may prioritise therapeutic window over anatomical completeness.

Time-course measurements can show whether changes in combination therapy are transient or sustained in human tissue models.

Human tissue organoid and chip models can be used to study biomarker discovery.

Adding flow, co-culture or matrix cues can change how a human tissue model reproduces compound efficacy.

Combination therapy is one reason human tissue organoids or chips are useful beyond conventional monolayer culture.

A fit-for-purpose human tissue model may prioritise dose response over anatomical completeness.

Therapeutic window is one reason human tissue organoids or chips are useful beyond conventional monolayer culture.

In human tissue models, target validation can be measured alongside cell morphology and viability.

Adding flow, co-culture or matrix cues can change how a human tissue model reproduces dose response.

Benchmarking target validation against primary tissue improves confidence in a human tissue model.

Donor-derived human tissue models can reveal person-to-person differences in target validation.

Mechanism of action is one reason human tissue organoids or chips are useful beyond conventional monolayer culture.

Time-course measurements can show whether changes in target validation are transient or sustained in human tissue models.

Researchers use human tissue models to investigate dose response in a human-relevant in vitro setting.

Researchers use human tissue models to investigate combination therapy in a human-relevant in vitro setting.

Time-course measurements can show whether changes in mechanism of action are transient or sustained in human tissue models.

Donor-derived human tissue models can reveal person-to-person differences in combination therapy.

In human tissue models, biomarker discovery can be measured alongside cell morphology and viability.

Adding flow, co-culture or matrix cues can change how a human tissue model reproduces therapeutic window.

Time-course measurements can show whether changes in compound efficacy are transient or sustained in human tissue models.

Benchmarking biomarker discovery against primary tissue improves confidence in a human tissue model.

Donor-derived human tissue models can reveal person-to-person differences in therapeutic window.

Donor-derived human tissue models can reveal person-to-person differences in dose response.

Time-course measurements can show whether changes in therapeutic window are transient or sustained in human tissue models.

A fit-for-purpose human tissue model may prioritise biomarker discovery over anatomical completeness.

In human tissue models, combination therapy can be measured alongside cell morphology and viability.

Disease-relevant perturbations can be introduced to test how human tissue models respond through biomarker discovery.

Researchers use human tissue models to investigate compound efficacy in a human-relevant in vitro setting.

In human tissue models, therapeutic window can be measured alongside cell morphology and viability.

Researchers use human tissue models to investigate biomarker discovery in a human-relevant in vitro setting.

Benchmarking mechanism of action against primary tissue improves confidence in a human tissue model.

Disease-relevant perturbations can be introduced to test how human tissue models respond through therapeutic window.

Adding flow, co-culture or matrix cues can change how a human tissue model reproduces biomarker discovery.

Adding flow, co-culture or matrix cues can change how a human tissue model reproduces combination therapy.

A fit-for-purpose human tissue model may prioritise target validation over anatomical completeness.

Time-course measurements can show whether changes in dose response are transient or sustained in human tissue models.

Adding flow, co-culture or matrix cues can change how a human tissue model reproduces mechanism of action.

Target validation is one reason human tissue organoids or chips are useful beyond conventional monolayer culture.

Benchmarking dose response against primary tissue improves confidence in a human tissue model.

Donor-derived human tissue models can reveal person-to-person differences in biomarker discovery.

Disease-relevant perturbations can be introduced to test how human tissue models respond through target validation.

Disease-relevant perturbations can be introduced to test how human tissue models respond through dose response.

Donor-derived human tissue models can reveal person-to-person differences in compound efficacy.

Dose response is one reason human tissue organoids or chips are useful beyond conventional monolayer culture.

Contractility is one reason cardiac organoids or chips are useful beyond conventional monolayer culture.

Donor-derived cardiac models can reveal person-to-person differences in cardiotoxicity.

Benchmarking contractility against primary tissue improves confidence in a cardiac model.

Adding flow, co-culture or matrix cues can change how a cardiac model reproduces force generation.

Researchers use cardiac models to investigate vascular function in a human-relevant in vitro setting.

Adding flow, co-culture or matrix cues can change how a cardiac model reproduces contractility.

In cardiac models, contractility can be measured alongside cell morphology and viability.

Electrophysiology is one reason cardiac organoids or chips are useful beyond conventional monolayer culture.

Disease-relevant perturbations can be introduced to test how cardiac models respond through force generation.

Researchers use cardiac models to investigate cardiotoxicity in a human-relevant in vitro setting.

In cardiac models, cardiotoxicity can be measured alongside cell morphology and viability.

Force generation is one reason cardiac organoids or chips are useful beyond conventional monolayer culture.

Adding flow, co-culture or matrix cues can change how a cardiac model reproduces electrophysiology.

Disease-relevant perturbations can be introduced to test how cardiac models respond through contractility.

In cardiac models, electrophysiology can be measured alongside cell morphology and viability.

In cardiac models, vascular function can be measured alongside cell morphology and viability.

Time-course measurements can show whether changes in cardiotoxicity are transient or sustained in cardiac models.

Benchmarking electrophysiology against primary tissue improves confidence in a cardiac model.

Benchmarking force generation against primary tissue improves confidence in a cardiac model.

Cardiac organoid and chip models can be used to study electrophysiology.

Donor-derived cardiac models can reveal person-to-person differences in electrophysiology.

Cardiotoxicity is one reason cardiac organoids or chips are useful beyond conventional monolayer culture.

Disease-relevant perturbations can be introduced to test how cardiac models respond through electrophysiology.

Time-course measurements can show whether changes in electrophysiology are transient or sustained in cardiac models.

Disease-relevant perturbations can be introduced to test how cardiac models respond through cardiotoxicity.

In cardiac models, force generation can be measured alongside cell morphology and viability.

Adding flow, co-culture or matrix cues can change how a cardiac model reproduces cardiotoxicity.

Donor-derived cardiac models can reveal person-to-person differences in contractility.

Researchers use cardiac models to investigate force generation in a human-relevant in vitro setting.

A fit-for-purpose cardiac model may prioritise cardiotoxicity over anatomical completeness.

A fit-for-purpose cardiac model may prioritise electrophysiology over anatomical completeness.

A fit-for-purpose cardiac model may prioritise force generation over anatomical completeness.

A fit-for-purpose cardiac model may prioritise contractility over anatomical completeness.

Vascular function is one reason cardiac organoids or chips are useful beyond conventional monolayer culture.

Cardiac organoid and chip models can be used to study vascular function.

A fit-for-purpose cardiac model may prioritise vascular function over anatomical completeness.

Benchmarking cardiotoxicity against primary tissue improves confidence in a cardiac model.

Researchers use cardiac models to investigate electrophysiology in a human-relevant in vitro setting.

Time-course measurements can show whether changes in contractility are transient or sustained in cardiac models.

Cardiac organoid and chip models can be used to study contractility.

Cardiac organoid and chip models can be used to study force generation.

Cardiac organoid and chip models can be used to study cardiotoxicity.

Time-course measurements can show whether changes in force generation are transient or sustained in cardiac models.

Donor-derived cardiac models can reveal person-to-person differences in force generation.

Researchers use cardiac models to investigate contractility in a human-relevant in vitro setting.

Adding flow, co-culture or matrix cues can change how a liver model reproduces fibrotic signalling.

In liver models, bile-related functions can be measured alongside cell morphology and viability.

In liver models, fibrotic signalling can be measured alongside cell morphology and viability.

Donor-derived liver models can reveal person-to-person differences in steatosis.

Adding flow, co-culture or matrix cues can change how a liver model reproduces steatosis.

A fit-for-purpose liver model may prioritise drug-induced liver injury over anatomical completeness.

Adding flow, co-culture or matrix cues can change how a liver model reproduces bile-related functions.

Time-course measurements can show whether changes in steatosis are transient or sustained in liver models.

Researchers use liver models to investigate drug-induced liver injury in a human-relevant in vitro setting.

Benchmarking bile-related functions against primary tissue improves confidence in a liver model.

Liver organoid and chip models can be used to study steatosis.

Donor-derived liver models can reveal person-to-person differences in drug metabolism.

Liver organoid and chip models can be used to study drug metabolism.

Donor-derived liver models can reveal person-to-person differences in drug-induced liver injury.

Time-course measurements can show whether changes in drug metabolism are transient or sustained in liver models.

A fit-for-purpose liver model may prioritise drug metabolism over anatomical completeness.

Time-course measurements can show whether changes in drug-induced liver injury are transient or sustained in liver models.

Researchers use liver models to investigate bile-related functions in a human-relevant in vitro setting.

Fibrotic signalling is one reason liver organoids or chips are useful beyond conventional monolayer culture.

In liver models, drug metabolism can be measured alongside cell morphology and viability.

Donor-derived liver models can reveal person-to-person differences in fibrotic signalling.

Disease-relevant perturbations can be introduced to test how liver models respond through drug metabolism.

Drug-induced liver injury is one reason liver organoids or chips are useful beyond conventional monolayer culture.

Time-course measurements can show whether changes in bile-related functions are transient or sustained in liver models.

Time-course measurements can show whether changes in fibrotic signalling are transient or sustained in liver models.

Bile-related functions is one reason liver organoids or chips are useful beyond conventional monolayer culture.

Disease-relevant perturbations can be introduced to test how liver models respond through fibrotic signalling.

Disease-relevant perturbations can be introduced to test how liver models respond through drug-induced liver injury.

Researchers use liver models to investigate drug metabolism in a human-relevant in vitro setting.

A fit-for-purpose liver model may prioritise fibrotic signalling over anatomical completeness.

Adding flow, co-culture or matrix cues can change how a liver model reproduces drug metabolism.

Liver organoid and chip models can be used to study fibrotic signalling.

Adding flow, co-culture or matrix cues can change how a liver model reproduces drug-induced liver injury.

In liver models, drug-induced liver injury can be measured alongside cell morphology and viability.

Drug metabolism is one reason liver organoids or chips are useful beyond conventional monolayer culture.

Liver organoid and chip models can be used to study bile-related functions.

Disease-relevant perturbations can be introduced to test how liver models respond through bile-related functions.

Disease-relevant perturbations can be introduced to test how liver models respond through steatosis.

Benchmarking drug metabolism against primary tissue improves confidence in a liver model.

Steatosis is one reason liver organoids or chips are useful beyond conventional monolayer culture.

Benchmarking drug-induced liver injury against primary tissue improves confidence in a liver model.

Donor-derived liver models can reveal person-to-person differences in bile-related functions.

Liver organoid and chip models can be used to study drug-induced liver injury.

A fit-for-purpose liver model may prioritise bile-related functions over anatomical completeness.

Benchmarking steatosis against primary tissue improves confidence in a liver model.

Benchmarking fibrotic signalling against primary tissue improves confidence in a liver model.

Researchers use liver models to investigate steatosis in a human-relevant in vitro setting.

In liver models, steatosis can be measured alongside cell morphology and viability.

A fit-for-purpose liver model may prioritise steatosis over anatomical completeness.

Researchers use liver models to investigate fibrotic signalling in a human-relevant in vitro setting.

Reusable hardware can reduce cost but requires robust cleaning and validation.

Many organ-on-a-chip devices use microfluidic channels to deliver nutrients, drugs and mechanical cues.

Kidney proximal-tubule chips can model transport processes under flow.

Bubble formation is a practical challenge because bubbles can disrupt flow and damage cells.

Multi-organ systems connect two or more tissue models to study inter-organ interactions.

Organoid tissues can be incorporated directly into chip devices.

Tubing material can adsorb compounds just as chip material can.

Flow verification is as important as checking cell phenotype.

Standardised connectors can simplify integration with pumps and analytical equipment.

Multi-organ chips can help study metabolites generated in one tissue and acting on another.

Shear stress can alter endothelial, epithelial and renal cell behaviour.

Model predictions can guide channel dimensions and pump settings.

Flow can make drug exposure more transient than in static wells.

Integrated pumps can make devices more self-contained.

Connecting organ models requires careful scaling of tissue size, medium volume and flow.

Alternative chip materials are being explored to reduce compound loss and improve manufacturability.

A very complex MPS may be unsuitable for early screening but valuable for later mechanistic studies.

Humidity control and device sealing can improve long experiments.

Some lung chips apply cyclic mechanical strain to mimic aspects of breathing motion.

Barrier chips can distinguish apical from basolateral exposure.

Immortalised cell lines improve consistency but can sacrifice physiological fidelity.

Microphysiological systems, or MPS, is a broader term that can include organ chips and other engineered tissue models.

Device sterilisation method must be compatible with the materials and biological components.

Device material can influence drug adsorption and therefore effective exposure.

Transparent device materials are useful for microscopy-based readouts.

Organ chips can recreate tissue-tissue interfaces such as epithelium next to endothelium.

Plate-compatible formats make robotic liquid handling easier.

Gravity-driven flow can reduce hardware requirements in some platforms.

Directional exposure matters for tissues that encounter compounds from one side in vivo.

Cell source can matter as much as device design.

Immune cells can be added transiently or continuously depending on the biological question.

Fit-for-purpose design is a central principle in MPS development.

Vascular channels can be lined with endothelial cells to reproduce blood-facing interfaces.

Organ chips can place different cell types in adjacent compartments separated by a porous membrane or matrix.

Small fluid volumes can make low-abundance biomarkers easier to detect, but evaporation can become more important.

Electrodes can be integrated into chips for electrical or barrier measurements.

Interface models are especially useful for studying transport, inflammation and barrier disruption.

Microbial communities can be introduced into gut or airway chips when containment and oxygen conditions are controlled.

Controlled oxygenation can model hypoxia or tissue-specific oxygen environments.

Computational fluid dynamics can estimate shear stress and flow distribution before experiments begin.

Extracellular matrix proteins can be patterned to guide where cells attach.

Pharmacokinetic behaviour can be explored by tracking compounds across linked compartments.

Human donor diversity can be incorporated by using cells from multiple individuals.

iPSC-derived cells offer scalable human material but may require maturation strategies.

Hydrogel stiffness can influence cell migration and differentiation.

Separate media circuits with controlled exchange can reduce conflicts between tissue-specific requirements.

Compartmentalisation allows researchers to study communication across tissue interfaces.

Co-culture can recreate paracrine signalling that is absent in monocultures.

Organ chips can create chemical gradients that are difficult to maintain in standard well plates.

Closed-channel designs can provide tighter control of perfusion and interfaces.

Throughput often trades off against biological complexity.

Soft lithography helped make early organ-chip prototyping widely accessible.

Primary cells may provide mature functions but can have limited availability and expansion.

Surface-to-volume ratio can strongly influence gas exchange and material interactions.

Shared medium is convenient for multi-organ systems but may not be optimal for every tissue.

Repeated dosing can be programmed by changing perfusion schedules.

Organ chips are often designed around a specific question rather than a full anatomical replica.

Biosensors can provide repeated measurements without removing tissue from the device.

Universal or compromise media can be used when different tissues must coexist.

Surface coatings are often required to support cell adhesion in microchannels.

Fluid flow can expose cells to shear stress that is absent from conventional static culture.

Some gut chips use flow and mechanical deformation to support intestinal-like physiology.

Microfluidics can also make experiments harder to operate, so usability matters for adoption.

Open-well microfluidic designs can simplify cell seeding and sampling.

Donor-specific chips can support research on variability in treatment response.

Microfluidic devices can support oxygen gradients across tissues.

Multiple readouts help distinguish a true biological effect from a device artefact.

Gene-edited isogenic controls can strengthen causal interpretation in chip studies.

Chip-based perfusion can improve access to nutrients and drugs around organoid tissues.

Peristaltic and syringe pumps offer precise flow but can increase tubing and setup complexity.

Dead volume in tubing can delay exposure changes and complicate pharmacokinetic interpretation.

Organ chips can be designed for optical access so live imaging remains possible.

Organ-chip experiments often combine engineering quality control with biological quality control.

Evaporation can change osmolality and compound concentration in microscale cultures.

Organ chips can support concentration-time profiles rather than only fixed concentrations.

Tracer dyes or particles can be used to characterise mixing and residence time.

A lung chip built for barrier injury may differ substantially from one built for immune-cell trafficking.

Microfabrication enables precise placement of channels, membranes and sensing elements.

Three-dimensional hydrogels can be incorporated into chips to support embedded cells.

Organ chips can model rare genetic disorders when patient-derived cells are available.

Perfused liver models can improve exposure control for metabolism and toxicity studies.

Channel geometry influences shear stress, residence time and transport.

Small-scale systems may require attention to nonspecific binding because surface-to-volume ratios are high.

Perfused immune cells can be used to study adhesion, migration and tissue infiltration.

Organ-chip readouts can include microscopy, secreted biomarkers, electrophysiology, force and molecular profiling.

Mechanical compression, stretch and flow can be combined in one device.

Flow rate is an experimental variable that can change cell phenotype.

Barrier integrity can be measured using permeability assays or electrical resistance in suitable devices.

Organ-chip mechanics can affect gene expression, morphology and function.

Microfluidic flow can continuously remove secreted products as well as deliver nutrients.

Organ chips can support repeated sampling of perfusate for time-course measurements.

Organ-chip systems can complement organoids by adding flow, interfaces and mechanical forces.

Some chips are single-use to reduce contamination and simplify workflow.

Organ-chip assays can be miniaturised into multi-unit plates for higher throughput.

Organ chips can be used to investigate human-specific drug responses that are difficult to infer from animal species.

Washout can be measured directly in continuously perfused systems.

Polydimethylsiloxane, or PDMS, is common in research chips but can absorb some hydrophobic compounds.

Pump choice affects flow stability, pulsatility and experimental complexity.

Injection moulding and other manufacturing methods can support larger-scale production.

Organ-on-a-chip systems use engineered culture environments to reproduce selected tissue functions under controlled conditions.

Time-course measurements can show whether changes in drug sensitivity are transient or sustained in tumour models.

Benchmarking tumour-stroma interactions against primary tissue improves confidence in a tumour model.

Adding flow, co-culture or matrix cues can change how a tumour model reproduces tumour-stroma interactions.

In tumour models, invasion can be measured alongside cell morphology and viability.

Tumour organoid and chip models can be used to study immune-cell interactions.

Time-course measurements can show whether changes in drug resistance are transient or sustained in tumour models.

Adding flow, co-culture or matrix cues can change how a tumour model reproduces immune-cell interactions.

Benchmarking immune-cell interactions against primary tissue improves confidence in a tumour model.

Tumour organoid and chip models can be used to study drug sensitivity.

Benchmarking drug resistance against primary tissue improves confidence in a tumour model.

Benchmarking biomarker response against primary tissue improves confidence in a tumour model.

A fit-for-purpose tumour model may prioritise biomarker response over anatomical completeness.

In tumour models, immune-cell interactions can be measured alongside cell morphology and viability.

Disease-relevant perturbations can be introduced to test how tumour models respond through invasion.

Time-course measurements can show whether changes in tumour-stroma interactions are transient or sustained in tumour models.

Clonal heterogeneity is one reason tumour organoids or chips are useful beyond conventional monolayer culture.

Donor-derived tumour models can reveal person-to-person differences in clonal heterogeneity.

A fit-for-purpose tumour model may prioritise invasion over anatomical completeness.

Immune-cell interactions is one reason tumour organoids or chips are useful beyond conventional monolayer culture.

Researchers use tumour models to investigate clonal heterogeneity in a human-relevant in vitro setting.

In tumour models, clonal heterogeneity can be measured alongside cell morphology and viability.

Researchers use tumour models to investigate tumour-stroma interactions in a human-relevant in vitro setting.

Tumour organoid and chip models can be used to study invasion.

Researchers use tumour models to investigate immune-cell interactions in a human-relevant in vitro setting.

Adding flow, co-culture or matrix cues can change how a tumour model reproduces invasion.

Time-course measurements can show whether changes in biomarker response are transient or sustained in tumour models.

In tumour models, biomarker response can be measured alongside cell morphology and viability.

Disease-relevant perturbations can be introduced to test how tumour models respond through drug sensitivity.

Researchers use tumour models to investigate drug resistance in a human-relevant in vitro setting.

Researchers use tumour models to investigate biomarker response in a human-relevant in vitro setting.

Tumour organoid and chip models can be used to study biomarker response.

In tumour models, drug sensitivity can be measured alongside cell morphology and viability.

Researchers use tumour models to investigate drug sensitivity in a human-relevant in vitro setting.

Invasion is one reason tumour organoids or chips are useful beyond conventional monolayer culture.

Adding flow, co-culture or matrix cues can change how a tumour model reproduces clonal heterogeneity.

Tumour organoid and chip models can be used to study tumour-stroma interactions.

Tumour organoid and chip models can be used to study drug resistance.

Drug resistance is one reason tumour organoids or chips are useful beyond conventional monolayer culture.

Benchmarking invasion against primary tissue improves confidence in a tumour model.

Donor-derived tumour models can reveal person-to-person differences in immune-cell interactions.

Disease-relevant perturbations can be introduced to test how tumour models respond through drug resistance.

A fit-for-purpose tumour model may prioritise clonal heterogeneity over anatomical completeness.

A fit-for-purpose tumour model may prioritise drug resistance over anatomical completeness.

Donor-derived tumour models can reveal person-to-person differences in invasion.

Adding flow, co-culture or matrix cues can change how a tumour model reproduces drug sensitivity.

Donor-derived tumour models can reveal person-to-person differences in drug resistance.

A fit-for-purpose tumour model may prioritise tumour-stroma interactions over anatomical completeness.

Benchmarking clonal heterogeneity against primary tissue improves confidence in a tumour model.

Time-course measurements can show whether changes in invasion are transient or sustained in tumour models.

Donor-derived tumour models can reveal person-to-person differences in tumour-stroma interactions.

Disease-relevant perturbations can be introduced to test how tumour models respond through immune-cell interactions.

Donor-derived tumour models can reveal person-to-person differences in drug sensitivity.

Tumour organoid and chip models can be used to study clonal heterogeneity.

Adding flow, co-culture or matrix cues can change how a tumour model reproduces biomarker response.

Adding flow, co-culture or matrix cues can change how a tumour model reproduces drug resistance.

Biomarker response is one reason tumour organoids or chips are useful beyond conventional monolayer culture.

Time-course measurements can show whether changes in clonal heterogeneity are transient or sustained in tumour models.

Tumour-stroma interactions is one reason tumour organoids or chips are useful beyond conventional monolayer culture.

Donor-derived tumour models can reveal person-to-person differences in biomarker response.

Disease-relevant perturbations can be introduced to test how tumour models respond through tumour-stroma interactions.

Benchmarking drug sensitivity against primary tissue improves confidence in a tumour model.

In tumour models, drug resistance can be measured alongside cell morphology and viability.

Disease-relevant perturbations can be introduced to test how tumour models respond through biomarker response.

Disease-relevant perturbations can be introduced to test how tumour models respond through clonal heterogeneity.

Drug sensitivity is one reason tumour organoids or chips are useful beyond conventional monolayer culture.

In tumour models, tumour-stroma interactions can be measured alongside cell morphology and viability.

A fit-for-purpose tumour model may prioritise immune-cell interactions over anatomical completeness.

Time-course measurements can show whether changes in immune-cell interactions are transient or sustained in tumour models.

Researchers use tumour models to investigate invasion in a human-relevant in vitro setting.

A fit-for-purpose tumour model may prioritise drug sensitivity over anatomical completeness.

Researchers use lung models to investigate bacterial infection in a human-relevant in vitro setting.

Time-course measurements can show whether changes in bacterial infection are transient or sustained in lung models.

Disease-relevant perturbations can be introduced to test how lung models respond through viral infection.

Benchmarking mucociliary biology against primary tissue improves confidence in a lung model.

Donor-derived lung models can reveal person-to-person differences in airway barrier function.

Viral infection is one reason lung organoids or chips are useful beyond conventional monolayer culture.

Lung organoid and chip models can be used to study airway barrier function.

In lung models, mucociliary biology can be measured alongside cell morphology and viability.

A fit-for-purpose lung model may prioritise inflammation over anatomical completeness.

A fit-for-purpose lung model may prioritise bacterial infection over anatomical completeness.

A fit-for-purpose lung model may prioritise viral infection over anatomical completeness.

In lung models, bacterial infection can be measured alongside cell morphology and viability.

Adding flow, co-culture or matrix cues can change how a lung model reproduces bacterial infection.

Adding flow, co-culture or matrix cues can change how a lung model reproduces viral infection.

Time-course measurements can show whether changes in mucociliary biology are transient or sustained in lung models.

Donor-derived lung models can reveal person-to-person differences in inflammation.

Researchers use lung models to investigate airway barrier function in a human-relevant in vitro setting.

Adding flow, co-culture or matrix cues can change how a lung model reproduces mucociliary biology.

A fit-for-purpose lung model may prioritise airway barrier function over anatomical completeness.

Lung organoid and chip models can be used to study viral infection.

Lung organoid and chip models can be used to study inflammation.

Lung organoid and chip models can be used to study mucociliary biology.

Time-course measurements can show whether changes in airway barrier function are transient or sustained in lung models.

Donor-derived lung models can reveal person-to-person differences in bacterial infection.

Donor-derived lung models can reveal person-to-person differences in viral infection.

In lung models, viral infection can be measured alongside cell morphology and viability.

Adding flow, co-culture or matrix cues can change how a lung model reproduces inflammation.

Disease-relevant perturbations can be introduced to test how lung models respond through bacterial infection.

Benchmarking airway barrier function against primary tissue improves confidence in a lung model.

Time-course measurements can show whether changes in viral infection are transient or sustained in lung models.

Researchers use lung models to investigate mucociliary biology in a human-relevant in vitro setting.

Disease-relevant perturbations can be introduced to test how lung models respond through inflammation.

A fit-for-purpose lung model may prioritise mucociliary biology over anatomical completeness.

Lung organoid and chip models can be used to study bacterial infection.

Adding flow, co-culture or matrix cues can change how a lung model reproduces airway barrier function.

Time-course measurements can show whether changes in inflammation are transient or sustained in lung models.

Benchmarking viral infection against primary tissue improves confidence in a lung model.

Disease-relevant perturbations can be introduced to test how lung models respond through airway barrier function.

Bacterial infection is one reason lung organoids or chips are useful beyond conventional monolayer culture.

In lung models, inflammation can be measured alongside cell morphology and viability.

Disease-relevant perturbations can be introduced to test how lung models respond through mucociliary biology.

Airway barrier function is one reason lung organoids or chips are useful beyond conventional monolayer culture.

Inflammation is one reason lung organoids or chips are useful beyond conventional monolayer culture.

In lung models, airway barrier function can be measured alongside cell morphology and viability.

Researchers use lung models to investigate inflammation in a human-relevant in vitro setting.

Benchmarking bacterial infection against primary tissue improves confidence in a lung model.

Benchmarking inflammation against primary tissue improves confidence in a lung model.

Researchers use lung models to investigate viral infection in a human-relevant in vitro setting.

Donor-derived lung models can reveal person-to-person differences in mucociliary biology.

Mucociliary biology is one reason lung organoids or chips are useful beyond conventional monolayer culture.

Engineered tissue organoid and chip models can be used to study nutrient gradients.

Time-course measurements can show whether changes in fluid shear stress are transient or sustained in engineered tissue models.

In engineered tissue models, fluid shear stress can be measured alongside cell morphology and viability.

Benchmarking fluid shear stress against primary tissue improves confidence in a engineered tissue model.

Matrix composition is one reason engineered tissue organoids or chips are useful beyond conventional monolayer culture.

A fit-for-purpose engineered tissue model may prioritise nutrient gradients over anatomical completeness.

Engineered tissue organoid and chip models can be used to study oxygen gradients.

A fit-for-purpose engineered tissue model may prioritise matrix composition over anatomical completeness.

A fit-for-purpose engineered tissue model may prioritise oxygen gradients over anatomical completeness.

Disease-relevant perturbations can be introduced to test how engineered tissue models respond through fluid shear stress.

Time-course measurements can show whether changes in oxygen gradients are transient or sustained in engineered tissue models.

In engineered tissue models, oxygen gradients can be measured alongside cell morphology and viability.

Time-course measurements can show whether changes in matrix stiffness are transient or sustained in engineered tissue models.

A fit-for-purpose engineered tissue model may prioritise matrix stiffness over anatomical completeness.

Matrix stiffness is one reason engineered tissue organoids or chips are useful beyond conventional monolayer culture.

Benchmarking matrix composition against primary tissue improves confidence in a engineered tissue model.

Fluid shear stress is one reason engineered tissue organoids or chips are useful beyond conventional monolayer culture.

Benchmarking oxygen gradients against primary tissue improves confidence in a engineered tissue model.

In engineered tissue models, nutrient gradients can be measured alongside cell morphology and viability.

Oxygen gradients is one reason engineered tissue organoids or chips are useful beyond conventional monolayer culture.

Donor-derived engineered tissue models can reveal person-to-person differences in matrix composition.

Adding flow, co-culture or matrix cues can change how a engineered tissue model reproduces matrix stiffness.

Adding flow, co-culture or matrix cues can change how a engineered tissue model reproduces fluid shear stress.

Engineered tissue organoid and chip models can be used to study matrix composition.

Disease-relevant perturbations can be introduced to test how engineered tissue models respond through oxygen gradients.

Benchmarking matrix stiffness against primary tissue improves confidence in a engineered tissue model.

Engineered tissue organoid and chip models can be used to study fluid shear stress.

Researchers use engineered tissue models to investigate nutrient gradients in a human-relevant in vitro setting.

Time-course measurements can show whether changes in matrix composition are transient or sustained in engineered tissue models.

Nutrient gradients is one reason engineered tissue organoids or chips are useful beyond conventional monolayer culture.

Engineered tissue organoid and chip models can be used to study matrix stiffness.

Donor-derived engineered tissue models can reveal person-to-person differences in fluid shear stress.

Adding flow, co-culture or matrix cues can change how a engineered tissue model reproduces oxygen gradients.

Disease-relevant perturbations can be introduced to test how engineered tissue models respond through matrix stiffness.

In engineered tissue models, matrix stiffness can be measured alongside cell morphology and viability.

Donor-derived engineered tissue models can reveal person-to-person differences in oxygen gradients.

Donor-derived engineered tissue models can reveal person-to-person differences in matrix stiffness.

Researchers use engineered tissue models to investigate matrix stiffness in a human-relevant in vitro setting.

In engineered tissue models, matrix composition can be measured alongside cell morphology and viability.

Researchers use engineered tissue models to investigate fluid shear stress in a human-relevant in vitro setting.

Researchers use engineered tissue models to investigate oxygen gradients in a human-relevant in vitro setting.

Disease-relevant perturbations can be introduced to test how engineered tissue models respond through matrix composition.

Adding flow, co-culture or matrix cues can change how a engineered tissue model reproduces matrix composition.

Researchers use engineered tissue models to investigate matrix composition in a human-relevant in vitro setting.

A fit-for-purpose engineered tissue model may prioritise fluid shear stress over anatomical completeness.

Adding flow, co-culture or matrix cues can change how a reproductive model reproduces hormone responsiveness.

Disease-relevant perturbations can be introduced to test how reproductive models respond through hormone responsiveness.

Disease-relevant perturbations can be introduced to test how reproductive models respond through placental barrier function.

Reproductive organoid and chip models can be used to study placental barrier function.

Disease-relevant perturbations can be introduced to test how reproductive models respond through implantation-related biology.

Adding flow, co-culture or matrix cues can change how a reproductive model reproduces placental barrier function.

Endometrial differentiation is one reason reproductive organoids or chips are useful beyond conventional monolayer culture.

In reproductive models, endometrial differentiation can be measured alongside cell morphology and viability.

Time-course measurements can show whether changes in endometrial differentiation are transient or sustained in reproductive models.

A fit-for-purpose reproductive model may prioritise endometrial differentiation over anatomical completeness.

Researchers use reproductive models to investigate hormone responsiveness in a human-relevant in vitro setting.

Researchers use reproductive models to investigate endometrial differentiation in a human-relevant in vitro setting.

Reproductive organoid and chip models can be used to study implantation-related biology.

In reproductive models, implantation-related biology can be measured alongside cell morphology and viability.

A fit-for-purpose reproductive model may prioritise hormone responsiveness over anatomical completeness.

Donor-derived reproductive models can reveal person-to-person differences in implantation-related biology.

Adding flow, co-culture or matrix cues can change how a reproductive model reproduces implantation-related biology.

Donor-derived reproductive models can reveal person-to-person differences in endometrial differentiation.

In reproductive models, hormone responsiveness can be measured alongside cell morphology and viability.

Adding flow, co-culture or matrix cues can change how a reproductive model reproduces endometrial differentiation.

Benchmarking implantation-related biology against primary tissue improves confidence in a reproductive model.

Placental barrier function is one reason reproductive organoids or chips are useful beyond conventional monolayer culture.

A fit-for-purpose reproductive model may prioritise implantation-related biology over anatomical completeness.

Reproductive organoid and chip models can be used to study endometrial differentiation.

Donor-derived reproductive models can reveal person-to-person differences in placental barrier function.

Hormone responsiveness is one reason reproductive organoids or chips are useful beyond conventional monolayer culture.

Time-course measurements can show whether changes in hormone responsiveness are transient or sustained in reproductive models.

Implantation-related biology is one reason reproductive organoids or chips are useful beyond conventional monolayer culture.

Donor-derived reproductive models can reveal person-to-person differences in hormone responsiveness.

Disease-relevant perturbations can be introduced to test how reproductive models respond through endometrial differentiation.

Reproductive organoid and chip models can be used to study hormone responsiveness.

Time-course measurements can show whether changes in placental barrier function are transient or sustained in reproductive models.

Benchmarking hormone responsiveness against primary tissue improves confidence in a reproductive model.

Benchmarking endometrial differentiation against primary tissue improves confidence in a reproductive model.

A fit-for-purpose reproductive model may prioritise placental barrier function over anatomical completeness.

Researchers use reproductive models to investigate implantation-related biology in a human-relevant in vitro setting.

In reproductive models, placental barrier function can be measured alongside cell morphology and viability.

Time-course measurements can show whether changes in implantation-related biology are transient or sustained in reproductive models.

Benchmarking placental barrier function against primary tissue improves confidence in a reproductive model.

Researchers use reproductive models to investigate placental barrier function in a human-relevant in vitro setting.

Brain organoid and chip models can be used to study regional identity.

Disease-relevant perturbations can be introduced to test how brain models respond through network activity.

Adding flow, co-culture or matrix cues can change how a brain model reproduces network activity.

A fit-for-purpose brain model may prioritise neuronal migration over anatomical completeness.

A fit-for-purpose brain model may prioritise neural differentiation over anatomical completeness.

In brain models, neurodevelopmental disease can be measured alongside cell morphology and viability.

Benchmarking synapse formation against primary tissue improves confidence in a brain model.

In brain models, synapse formation can be measured alongside cell morphology and viability.

Researchers use brain models to investigate regional identity in a human-relevant in vitro setting.

Adding flow, co-culture or matrix cues can change how a brain model reproduces neural differentiation.

Benchmarking regional identity against primary tissue improves confidence in a brain model.

Researchers use brain models to investigate neural differentiation in a human-relevant in vitro setting.

Disease-relevant perturbations can be introduced to test how brain models respond through neurodevelopmental disease.

Time-course measurements can show whether changes in regional identity are transient or sustained in brain models.

Researchers use brain models to investigate synapse formation in a human-relevant in vitro setting.

Donor-derived brain models can reveal person-to-person differences in neuronal migration.

Brain organoid and chip models can be used to study neural differentiation.

Adding flow, co-culture or matrix cues can change how a brain model reproduces neuronal migration.

In brain models, neural differentiation can be measured alongside cell morphology and viability.

Time-course measurements can show whether changes in synapse formation are transient or sustained in brain models.

A fit-for-purpose brain model may prioritise regional identity over anatomical completeness.

Disease-relevant perturbations can be introduced to test how brain models respond through synapse formation.

Neurodevelopmental disease is one reason brain organoids or chips are useful beyond conventional monolayer culture.

Researchers use brain models to investigate neurodevelopmental disease in a human-relevant in vitro setting.

Network activity is one reason brain organoids or chips are useful beyond conventional monolayer culture.

Researchers use brain models to investigate neuronal migration in a human-relevant in vitro setting.

In brain models, network activity can be measured alongside cell morphology and viability.

A fit-for-purpose brain model may prioritise synapse formation over anatomical completeness.

In brain models, regional identity can be measured alongside cell morphology and viability.

Benchmarking neuronal migration against primary tissue improves confidence in a brain model.

Time-course measurements can show whether changes in neurodevelopmental disease are transient or sustained in brain models.

In brain models, neuronal migration can be measured alongside cell morphology and viability.

Adding flow, co-culture or matrix cues can change how a brain model reproduces regional identity.

Benchmarking neural differentiation against primary tissue improves confidence in a brain model.

Donor-derived brain models can reveal person-to-person differences in synapse formation.

Time-course measurements can show whether changes in neuronal migration are transient or sustained in brain models.

Adding flow, co-culture or matrix cues can change how a brain model reproduces synapse formation.

Donor-derived brain models can reveal person-to-person differences in regional identity.

A fit-for-purpose brain model may prioritise neurodevelopmental disease over anatomical completeness.

Researchers use brain models to investigate network activity in a human-relevant in vitro setting.

Brain organoid and chip models can be used to study neurodevelopmental disease.

Regional identity is one reason brain organoids or chips are useful beyond conventional monolayer culture.

Brain organoid and chip models can be used to study neuronal migration.

Time-course measurements can show whether changes in network activity are transient or sustained in brain models.

Adding flow, co-culture or matrix cues can change how a brain model reproduces neurodevelopmental disease.

Disease-relevant perturbations can be introduced to test how brain models respond through neural differentiation.

Donor-derived brain models can reveal person-to-person differences in neurodevelopmental disease.

Donor-derived brain models can reveal person-to-person differences in neural differentiation.

Benchmarking network activity against primary tissue improves confidence in a brain model.

A fit-for-purpose brain model may prioritise network activity over anatomical completeness.

Disease-relevant perturbations can be introduced to test how brain models respond through regional identity.

Benchmarking neurodevelopmental disease against primary tissue improves confidence in a brain model.

Synapse formation is one reason brain organoids or chips are useful beyond conventional monolayer culture.

Brain organoid and chip models can be used to study synapse formation.

Neuronal migration is one reason brain organoids or chips are useful beyond conventional monolayer culture.

Time-course measurements can show whether changes in neural differentiation are transient or sustained in brain models.

Donor-derived brain models can reveal person-to-person differences in network activity.

Brain organoid and chip models can be used to study network activity.

Disease-relevant perturbations can be introduced to test how brain models respond through neuronal migration.

Neural differentiation is one reason brain organoids or chips are useful beyond conventional monolayer culture.

Time-course measurements can show whether changes in glomerular filtration-related biology are transient or sustained in kidney models.

Kidney organoid and chip models can be used to study fluid shear stress.

Donor-derived kidney models can reveal person-to-person differences in nephrotoxicity.

In kidney models, proximal-tubule transport can be measured alongside cell morphology and viability.

Benchmarking fluid shear stress against primary tissue improves confidence in a kidney model.

Disease-relevant perturbations can be introduced to test how kidney models respond through proximal-tubule transport.

Time-course measurements can show whether changes in fluid shear stress are transient or sustained in kidney models.

Adding flow, co-culture or matrix cues can change how a kidney model reproduces proximal-tubule transport.

Donor-derived kidney models can reveal person-to-person differences in glomerular filtration-related biology.

A fit-for-purpose kidney model may prioritise glomerular filtration-related biology over anatomical completeness.

Adding flow, co-culture or matrix cues can change how a kidney model reproduces glomerular filtration-related biology.

Time-course measurements can show whether changes in nephrotoxicity are transient or sustained in kidney models.

Kidney organoid and chip models can be used to study drug secretion.

Researchers use kidney models to investigate drug secretion in a human-relevant in vitro setting.

Disease-relevant perturbations can be introduced to test how kidney models respond through nephrotoxicity.

Adding flow, co-culture or matrix cues can change how a kidney model reproduces nephrotoxicity.

Benchmarking nephrotoxicity against primary tissue improves confidence in a kidney model.

Kidney organoid and chip models can be used to study nephrotoxicity.

Researchers use kidney models to investigate fluid shear stress in a human-relevant in vitro setting.

Disease-relevant perturbations can be introduced to test how kidney models respond through fluid shear stress.

Researchers use kidney models to investigate nephrotoxicity in a human-relevant in vitro setting.

In kidney models, nephrotoxicity can be measured alongside cell morphology and viability.

Benchmarking proximal-tubule transport against primary tissue improves confidence in a kidney model.

Glomerular filtration-related biology is one reason kidney organoids or chips are useful beyond conventional monolayer culture.

Researchers use kidney models to investigate proximal-tubule transport in a human-relevant in vitro setting.

A fit-for-purpose kidney model may prioritise fluid shear stress over anatomical completeness.

Proximal-tubule transport is one reason kidney organoids or chips are useful beyond conventional monolayer culture.

Disease-relevant perturbations can be introduced to test how kidney models respond through glomerular filtration-related biology.

A fit-for-purpose kidney model may prioritise nephrotoxicity over anatomical completeness.

Donor-derived kidney models can reveal person-to-person differences in proximal-tubule transport.

Time-course measurements can show whether changes in proximal-tubule transport are transient or sustained in kidney models.

Researchers use kidney models to investigate glomerular filtration-related biology in a human-relevant in vitro setting.

In kidney models, drug secretion can be measured alongside cell morphology and viability.

Fluid shear stress is one reason kidney organoids or chips are useful beyond conventional monolayer culture.

Donor-derived kidney models can reveal person-to-person differences in fluid shear stress.

A fit-for-purpose kidney model may prioritise drug secretion over anatomical completeness.

Drug secretion is one reason kidney organoids or chips are useful beyond conventional monolayer culture.

Kidney organoid and chip models can be used to study glomerular filtration-related biology.

Adding flow, co-culture or matrix cues can change how a kidney model reproduces fluid shear stress.

In kidney models, glomerular filtration-related biology can be measured alongside cell morphology and viability.

A fit-for-purpose kidney model may prioritise proximal-tubule transport over anatomical completeness.

Nephrotoxicity is one reason kidney organoids or chips are useful beyond conventional monolayer culture.

Benchmarking glomerular filtration-related biology against primary tissue improves confidence in a kidney model.

In kidney models, fluid shear stress can be measured alongside cell morphology and viability.

Kidney organoid and chip models can be used to study proximal-tubule transport.

Adding flow, co-culture or matrix cues can change how a organoid and chip model reproduces automated image segmentation.

Researchers use organoid and chip models to investigate automated image segmentation in a human-relevant in vitro setting.

Benchmarking morphological phenotyping against primary tissue improves confidence in a organoid and chip model.

In organoid and chip models, morphological phenotyping can be measured alongside cell morphology and viability.

Time-course measurements can show whether changes in single-cell transcriptomics are transient or sustained in organoid and chip models.

A fit-for-purpose organoid and chip model may prioritise morphological phenotyping over anatomical completeness.

Time-course measurements can show whether changes in morphological phenotyping are transient or sustained in organoid and chip models.

Donor-derived organoid and chip models can reveal person-to-person differences in single-cell transcriptomics.

Organoid and chip organoid and chip models can be used to study morphological phenotyping.

Morphological phenotyping is one reason organoid and chip organoids or chips are useful beyond conventional monolayer culture.

Single-cell transcriptomics is one reason organoid and chip organoids or chips are useful beyond conventional monolayer culture.

Automated image segmentation is one reason organoid and chip organoids or chips are useful beyond conventional monolayer culture.

Time-course measurements can show whether changes in automated image segmentation are transient or sustained in organoid and chip models.

Adding flow, co-culture or matrix cues can change how a organoid and chip model reproduces morphological phenotyping.

Disease-relevant perturbations can be introduced to test how organoid and chip models respond through automated image segmentation.

A fit-for-purpose organoid and chip model may prioritise automated image segmentation over anatomical completeness.

Adding flow, co-culture or matrix cues can change how a organoid and chip model reproduces single-cell transcriptomics.

In organoid and chip models, automated image segmentation can be measured alongside cell morphology and viability.

Researchers use organoid and chip models to investigate morphological phenotyping in a human-relevant in vitro setting.

Researchers use organoid and chip models to investigate single-cell transcriptomics in a human-relevant in vitro setting.

In organoid and chip models, single-cell transcriptomics can be measured alongside cell morphology and viability.

Organoid and chip organoid and chip models can be used to study single-cell transcriptomics.

Benchmarking automated image segmentation against primary tissue improves confidence in a organoid and chip model.

Benchmarking single-cell transcriptomics against primary tissue improves confidence in a organoid and chip model.

Donor-derived organoid and chip models can reveal person-to-person differences in automated image segmentation.

Disease-relevant perturbations can be introduced to test how organoid and chip models respond through morphological phenotyping.

Organoid and chip organoid and chip models can be used to study automated image segmentation.

A fit-for-purpose organoid and chip model may prioritise single-cell transcriptomics over anatomical completeness.

Donor-derived organoid and chip models can reveal person-to-person differences in morphological phenotyping.

Disease-relevant perturbations can be introduced to test how organoid and chip models respond through single-cell transcriptomics.

Disease-relevant perturbations can be introduced to test how pancreatic models respond through beta-cell function.

A fit-for-purpose pancreatic model may prioritise insulin secretion over anatomical completeness.

Benchmarking endocrine differentiation against primary tissue improves confidence in a pancreatic model.

Beta-cell function is one reason pancreatic organoids or chips are useful beyond conventional monolayer culture.

Insulin secretion is one reason pancreatic organoids or chips are useful beyond conventional monolayer culture.

Pancreatic organoid and chip models can be used to study insulin secretion.

Disease-relevant perturbations can be introduced to test how pancreatic models respond through endocrine differentiation.

Time-course measurements can show whether changes in insulin secretion are transient or sustained in pancreatic models.

Time-course measurements can show whether changes in glucose responsiveness are transient or sustained in pancreatic models.

Disease-relevant perturbations can be introduced to test how pancreatic models respond through insulin secretion.

Pancreatic organoid and chip models can be used to study endocrine differentiation.

A fit-for-purpose pancreatic model may prioritise beta-cell function over anatomical completeness.

Adding flow, co-culture or matrix cues can change how a pancreatic model reproduces beta-cell function.

A fit-for-purpose pancreatic model may prioritise endocrine differentiation over anatomical completeness.

Donor-derived pancreatic models can reveal person-to-person differences in endocrine differentiation.

Endocrine differentiation is one reason pancreatic organoids or chips are useful beyond conventional monolayer culture.

Donor-derived pancreatic models can reveal person-to-person differences in beta-cell function.

Pancreatic organoid and chip models can be used to study glucose responsiveness.

Adding flow, co-culture or matrix cues can change how a pancreatic model reproduces insulin secretion.

Researchers use pancreatic models to investigate endocrine differentiation in a human-relevant in vitro setting.

Disease-relevant perturbations can be introduced to test how pancreatic models respond through glucose responsiveness.

Pancreatic organoid and chip models can be used to study beta-cell function.

Glucose responsiveness is one reason pancreatic organoids or chips are useful beyond conventional monolayer culture.

In pancreatic models, beta-cell function can be measured alongside cell morphology and viability.

In pancreatic models, insulin secretion can be measured alongside cell morphology and viability.

Researchers use pancreatic models to investigate insulin secretion in a human-relevant in vitro setting.

Researchers use pancreatic models to investigate glucose responsiveness in a human-relevant in vitro setting.

Donor-derived pancreatic models can reveal person-to-person differences in insulin secretion.

Donor-derived pancreatic models can reveal person-to-person differences in glucose responsiveness.

Time-course measurements can show whether changes in endocrine differentiation are transient or sustained in pancreatic models.

Adding flow, co-culture or matrix cues can change how a pancreatic model reproduces glucose responsiveness.

Researchers use pancreatic models to investigate beta-cell function in a human-relevant in vitro setting.

In pancreatic models, endocrine differentiation can be measured alongside cell morphology and viability.

Benchmarking insulin secretion against primary tissue improves confidence in a pancreatic model.

Benchmarking glucose responsiveness against primary tissue improves confidence in a pancreatic model.

Benchmarking beta-cell function against primary tissue improves confidence in a pancreatic model.

A fit-for-purpose pancreatic model may prioritise glucose responsiveness over anatomical completeness.

Adding flow, co-culture or matrix cues can change how a pancreatic model reproduces endocrine differentiation.

In pancreatic models, glucose responsiveness can be measured alongside cell morphology and viability.

Time-course measurements can show whether changes in beta-cell function are transient or sustained in pancreatic models.

Donor-derived human-based models can reveal person-to-person differences in human variability.

Benchmarking animal replacement in defined contexts against primary tissue improves confidence in a human-based model.

Donor-derived human-based models can reveal person-to-person differences in animal replacement in defined contexts.

Researchers use human-based models to investigate human variability in a human-relevant in vitro setting.

Human-based organoid and chip models can be used to study 3Rs implementation.

Time-course measurements can show whether changes in 3Rs implementation are transient or sustained in human-based models.

In human-based models, 3Rs implementation can be measured alongside cell morphology and viability.

A fit-for-purpose human-based model may prioritise refinement of study design over anatomical completeness.

Benchmarking mechanistic research against primary tissue improves confidence in a human-based model.

A fit-for-purpose human-based model may prioritise 3Rs implementation over anatomical completeness.

In human-based models, mechanistic research can be measured alongside cell morphology and viability.

Disease-relevant perturbations can be introduced to test how human-based models respond through human variability.

Time-course measurements can show whether changes in human variability are transient or sustained in human-based models.

3Rs implementation is one reason human-based organoids or chips are useful beyond conventional monolayer culture.

Refinement of study design is one reason human-based organoids or chips are useful beyond conventional monolayer culture.

A fit-for-purpose human-based model may prioritise mechanistic research over anatomical completeness.

In human-based models, animal replacement in defined contexts can be measured alongside cell morphology and viability.

A fit-for-purpose human-based model may prioritise human variability over anatomical completeness.

Benchmarking 3Rs implementation against primary tissue improves confidence in a human-based model.

Human-based organoid and chip models can be used to study animal replacement in defined contexts.

Time-course measurements can show whether changes in animal replacement in defined contexts are transient or sustained in human-based models.

Adding flow, co-culture or matrix cues can change how a human-based model reproduces mechanistic research.

In human-based models, human variability can be measured alongside cell morphology and viability.

Adding flow, co-culture or matrix cues can change how a human-based model reproduces human variability.

Researchers use human-based models to investigate refinement of study design in a human-relevant in vitro setting.

Mechanistic research is one reason human-based organoids or chips are useful beyond conventional monolayer culture.

In human-based models, refinement of study design can be measured alongside cell morphology and viability.

Researchers use human-based models to investigate 3Rs implementation in a human-relevant in vitro setting.

Animal replacement in defined contexts is one reason human-based organoids or chips are useful beyond conventional monolayer culture.

Human-based organoid and chip models can be used to study mechanistic research.

Donor-derived human-based models can reveal person-to-person differences in mechanistic research.

Adding flow, co-culture or matrix cues can change how a human-based model reproduces animal replacement in defined contexts.

Human-based organoid and chip models can be used to study human variability.

Researchers use human-based models to investigate mechanistic research in a human-relevant in vitro setting.

Benchmarking human variability against primary tissue improves confidence in a human-based model.

Adding flow, co-culture or matrix cues can change how a human-based model reproduces 3Rs implementation.

Human variability is one reason human-based organoids or chips are useful beyond conventional monolayer culture.

Time-course measurements can show whether changes in mechanistic research are transient or sustained in human-based models.

Disease-relevant perturbations can be introduced to test how human-based models respond through animal replacement in defined contexts.

Researchers use human-based models to investigate animal replacement in defined contexts in a human-relevant in vitro setting.

Disease-relevant perturbations can be introduced to test how human-based models respond through 3Rs implementation.

Disease-relevant perturbations can be introduced to test how human-based models respond through mechanistic research.

A fit-for-purpose human-based model may prioritise animal replacement in defined contexts over anatomical completeness.

Donor-derived human-based models can reveal person-to-person differences in 3Rs implementation.

Human-based organoid and chip models can be used to study refinement of study design.

Benchmarking mechanistic toxicology against primary tissue improves confidence in a human tissue model.

Adding flow, co-culture or matrix cues can change how a human tissue model reproduces assay qualification.

Mechanistic toxicology is one reason human tissue organoids or chips are useful beyond conventional monolayer culture.

Time-course measurements can show whether changes in organ-specific toxicity are transient or sustained in human tissue models.

A fit-for-purpose human tissue model may prioritise reference compound response over anatomical completeness.

Benchmarking recovery after exposure against primary tissue improves confidence in a human tissue model.

Time-course measurements can show whether changes in assay qualification are transient or sustained in human tissue models.

Human tissue organoid and chip models can be used to study dose-dependent injury.

Researchers use human tissue models to investigate dose-dependent injury in a human-relevant in vitro setting.

Assay qualification is one reason human tissue organoids or chips are useful beyond conventional monolayer culture.

Adding flow, co-culture or matrix cues can change how a human tissue model reproduces recovery after exposure.

Human tissue organoid and chip models can be used to study mechanistic toxicology.

Human tissue organoid and chip models can be used to study organ-specific toxicity.

Time-course measurements can show whether changes in mechanistic toxicology are transient or sustained in human tissue models.

Dose-dependent injury is one reason human tissue organoids or chips are useful beyond conventional monolayer culture.

Benchmarking reference compound response against primary tissue improves confidence in a human tissue model.

Disease-relevant perturbations can be introduced to test how human tissue models respond through assay qualification.

Adding flow, co-culture or matrix cues can change how a human tissue model reproduces reference compound response.

In human tissue models, mechanistic toxicology can be measured alongside cell morphology and viability.

Researchers use human tissue models to investigate reference compound response in a human-relevant in vitro setting.

A fit-for-purpose human tissue model may prioritise mechanistic toxicology over anatomical completeness.

Donor-derived human tissue models can reveal person-to-person differences in organ-specific toxicity.

Donor-derived human tissue models can reveal person-to-person differences in assay qualification.

A fit-for-purpose human tissue model may prioritise recovery after exposure over anatomical completeness.

Researchers use human tissue models to investigate mechanistic toxicology in a human-relevant in vitro setting.

In human tissue models, reference compound response can be measured alongside cell morphology and viability.

Disease-relevant perturbations can be introduced to test how human tissue models respond through organ-specific toxicity.

In human tissue models, recovery after exposure can be measured alongside cell morphology and viability.

Benchmarking assay qualification against primary tissue improves confidence in a human tissue model.

Human tissue organoid and chip models can be used to study assay qualification.

Disease-relevant perturbations can be introduced to test how human tissue models respond through reference compound response.

Disease-relevant perturbations can be introduced to test how human tissue models respond through recovery after exposure.

Donor-derived human tissue models can reveal person-to-person differences in mechanistic toxicology.

Researchers use human tissue models to investigate organ-specific toxicity in a human-relevant in vitro setting.

Donor-derived human tissue models can reveal person-to-person differences in dose-dependent injury.

Time-course measurements can show whether changes in dose-dependent injury are transient or sustained in human tissue models.

Adding flow, co-culture or matrix cues can change how a human tissue model reproduces mechanistic toxicology.

Time-course measurements can show whether changes in recovery after exposure are transient or sustained in human tissue models.

Human tissue organoid and chip models can be used to study reference compound response.

A fit-for-purpose human tissue model may prioritise assay qualification over anatomical completeness.

A fit-for-purpose human tissue model may prioritise organ-specific toxicity over anatomical completeness.

Benchmarking dose-dependent injury against primary tissue improves confidence in a human tissue model.

Researchers use human tissue models to investigate assay qualification in a human-relevant in vitro setting.

Recovery after exposure is one reason human tissue organoids or chips are useful beyond conventional monolayer culture.

In human tissue models, organ-specific toxicity can be measured alongside cell morphology and viability.

Researchers use human tissue models to investigate recovery after exposure in a human-relevant in vitro setting.

Time-course measurements can show whether changes in reference compound response are transient or sustained in human tissue models.

Donor-derived human tissue models can reveal person-to-person differences in recovery after exposure.

Disease-relevant perturbations can be introduced to test how human tissue models respond through mechanistic toxicology.

Adding flow, co-culture or matrix cues can change how a human tissue model reproduces organ-specific toxicity.

Human tissue organoid and chip models can be used to study recovery after exposure.

Adding flow, co-culture or matrix cues can change how a human tissue model reproduces dose-dependent injury.

In human tissue models, dose-dependent injury can be measured alongside cell morphology and viability.

Donor-derived human tissue models can reveal person-to-person differences in reference compound response.

Benchmarking organ-specific toxicity against primary tissue improves confidence in a human tissue model.

In human tissue models, assay qualification can be measured alongside cell morphology and viability.

Reference compound response is one reason human tissue organoids or chips are useful beyond conventional monolayer culture.

Disease-relevant perturbations can be introduced to test how human tissue models respond through dose-dependent injury.

Organ-specific toxicity is one reason human tissue organoids or chips are useful beyond conventional monolayer culture.

A fit-for-purpose human tissue model may prioritise dose-dependent injury over anatomical completeness.

Researchers use organoid and mps models to investigate acceptance criteria in a human-relevant in vitro setting.

Adding flow, co-culture or matrix cues can change how a organoid and mps model reproduces operator variability.

A fit-for-purpose organoid and mps model may prioritise acceptance criteria over anatomical completeness.

Acceptance criteria is one reason organoid and mps organoids or chips are useful beyond conventional monolayer culture.

Donor-derived organoid and mps models can reveal person-to-person differences in batch-to-batch reproducibility.

Benchmarking operator variability against primary tissue improves confidence in a organoid and mps model.

Organoid and MPS organoid and chip models can be used to study reference controls.

In organoid and mps models, operator variability can be measured alongside cell morphology and viability.

Reference controls is one reason organoid and mps organoids or chips are useful beyond conventional monolayer culture.

Benchmarking acceptance criteria against primary tissue improves confidence in a organoid and mps model.

In organoid and mps models, acceptance criteria can be measured alongside cell morphology and viability.

Time-course measurements can show whether changes in acceptance criteria are transient or sustained in organoid and mps models.

Batch-to-batch reproducibility is one reason organoid and mps organoids or chips are useful beyond conventional monolayer culture.

In organoid and mps models, reference controls can be measured alongside cell morphology and viability.

Organoid and MPS organoid and chip models can be used to study operator variability.

Time-course measurements can show whether changes in batch-to-batch reproducibility are transient or sustained in organoid and mps models.

Organoid and MPS organoid and chip models can be used to study batch-to-batch reproducibility.

Operator variability is one reason organoid and mps organoids or chips are useful beyond conventional monolayer culture.

A fit-for-purpose organoid and mps model may prioritise batch-to-batch reproducibility over anatomical completeness.

Disease-relevant perturbations can be introduced to test how organoid and mps models respond through reference controls.

Donor-derived organoid and mps models can reveal person-to-person differences in reference controls.

A fit-for-purpose organoid and mps model may prioritise operator variability over anatomical completeness.

Benchmarking reference controls against primary tissue improves confidence in a organoid and mps model.

In organoid and mps models, batch-to-batch reproducibility can be measured alongside cell morphology and viability.

Donor-derived organoid and mps models can reveal person-to-person differences in operator variability.

Disease-relevant perturbations can be introduced to test how organoid and mps models respond through operator variability.

Adding flow, co-culture or matrix cues can change how a organoid and mps model reproduces acceptance criteria.

Time-course measurements can show whether changes in operator variability are transient or sustained in organoid and mps models.

Researchers use organoid and mps models to investigate operator variability in a human-relevant in vitro setting.

Disease-relevant perturbations can be introduced to test how organoid and mps models respond through batch-to-batch reproducibility.

A fit-for-purpose organoid and mps model may prioritise reference controls over anatomical completeness.

Benchmarking batch-to-batch reproducibility against primary tissue improves confidence in a organoid and mps model.

Time-course measurements can show whether changes in reference controls are transient or sustained in organoid and mps models.

Donor-derived organoid and mps models can reveal person-to-person differences in acceptance criteria.

Researchers use organoid and mps models to investigate reference controls in a human-relevant in vitro setting.

Adding flow, co-culture or matrix cues can change how a organoid and mps model reproduces reference controls.

Organoid and MPS organoid and chip models can be used to study acceptance criteria.

Adding flow, co-culture or matrix cues can change how a organoid and mps model reproduces batch-to-batch reproducibility.

Researchers use organoid and mps models to investigate batch-to-batch reproducibility in a human-relevant in vitro setting.

Disease-relevant perturbations can be introduced to test how organoid and mps models respond through acceptance criteria.

Organoids usually model only part of an organ rather than every structure and function of the full organ.

Multi-omics can help separate morphological similarity from molecular similarity.

Some organoid systems model early development more closely than adult physiology.

Synthetic matrices are being developed to reduce variability associated with animal-derived extracellular matrices.

Organoid-derived cells can be plated into 2D formats when a flat geometry is experimentally advantageous.

Likewise, functional similarity in one assay does not mean every molecular pathway is faithfully reproduced.

Image-based phenotyping is widely used because organoids produce rich morphological information.

Organoid studies increasingly use quantitative benchmarks instead of relying only on representative images.

Assembloids are used to study interactions between distinct regions or cell populations.

Genetic engineering can be combined with organoids to study the effects of defined mutations.

Organoids can model interactions between epithelium and pathogens, depending on how the relevant surface is accessed.

Some organoid systems orient their apical surface inward, which can complicate access to luminal biology.

Perfusion can support nutrient delivery and expose organoid tissues to physiologically relevant flow.

Organoid models can be benchmarked against primary tissue, clinical samples and established reference compounds.

Organoids can be dissociated and re-formed, although this may change cell state and architecture.

Reference drugs can help demonstrate whether an organoid assay responds in biologically expected directions.

Organoid-to-organoid variability can be biologically informative but also complicates assay standardisation.

Not every organoid protocol produces the same degree of maturation.

Organoid models can be paired with computational analysis to quantify shape, texture and growth kinetics.

A simpler 2D assay may outperform an organoid assay when throughput and a single molecular readout are the priority.

Growth-factor cocktails are tailored to the tissue identity researchers want an organoid to maintain or acquire.

Organoid studies can test whether a phenotype is consistent across sexes, ages or genetic backgrounds when diverse donors are available.

Passage number can affect organoid phenotype, growth and differentiation.

Organoids can be integrated with microfluidic systems to provide flow, controlled gradients or mechanical cues.

Organoid culture can preserve donor-specific genetics without reproducing every aspect of donor physiology.

Organoid assays can be miniaturised into multi-well formats for higher-throughput studies.

Functional readouts such as secretion, transport or electrophysiology can add biological meaning beyond imaging alone.

Large organoids can develop hypoxic or necrotic regions if diffusion is insufficient.

Organoid growth rate can itself be a phenotype in developmental, disease or drug-response studies.

Batch effects can arise from cell source, matrix lot, medium composition and handling.

Other organoid types are more terminally differentiated and have limited expansion capacity.

Organoids usually involve self-organisation and tissue-specific differentiation beyond simple cell aggregation.

Adding vasculature-like components can improve modelling of cell-cell interactions and transport.

Cell density at seeding can influence organoid number, size and composition.

Organoids are three-dimensional cell cultures designed to reproduce selected features of real tissues.

Organoids can sometimes be fused with other organoid types to create assembloids.

Replicates should account for both technical variation and biological donor variation.

Organoids can be generated from healthy tissue as well as diseased tissue.

Well-designed negative and positive controls are as important in organoid experiments as in conventional assays.

Donor-to-donor variability is often a strength for population studies but a challenge for assay precision.

Organoids can reduce the gap between conventional monolayer culture and intact tissue, but they do not eliminate it.

Mechanical properties of the culture matrix can influence organoid growth and differentiation.

Organoid size can influence nutrient, oxygen and signalling gradients inside the model.

Drug penetration can vary across an organoid, creating concentration gradients similar to some solid tissues.

Temporal control of signalling cues is important because the same pathway can have different effects at different stages.

Organoid protocols often balance self-renewal signals with differentiation signals.

A useful organoid model needs a defined context of use rather than a claim that it reproduces an entire organ.

Gene-expression similarity to native tissue does not guarantee equivalent functional behaviour.

Organoid fusion can occur unintentionally when structures are cultured too closely together.

Extracellular matrix or matrix-like support is commonly used to help organoids establish three-dimensional architecture.

Patient-derived organoid biobanks can support comparative studies across many donors.

Standardising starting cell number can improve comparability between wells.

Chemical, inflammatory or mechanical stress can be introduced in controlled ways to create disease-relevant phenotypes.

Adult stem cell-derived organoids and pluripotent stem cell-derived organoids often differ in developmental state and cell composition.

Organoids can complement animal models, clinical samples and computational models rather than serving as a universal replacement.

Organoid morphology can be informative but should not be treated as a complete measure of function.

Organoids can support repeated sampling of culture medium without destroying the tissue.

Patient-derived organoids can preserve disease-associated features that are lost in some immortalised cell lines.

Reference tissue data can help determine which features of an organoid are physiologically relevant.

Single-cell sequencing is often used to compare organoid cell states with those found in native tissue.

Maturation strategies can include longer culture, mechanical stimulation, co-culture or transplantation.

Microinjection can deliver microbes, drugs or other agents into enclosed organoid lumens.

Some organoid protocols use air-liquid interface culture to improve epithelial differentiation.

CRISPR-edited organoids can help distinguish causal mutations from background genetic variation.

Organoid cultures often require careful control of temperature, medium changes and matrix handling.

Organoids can be used to study tissue development because they reproduce aspects of cell differentiation and spatial organisation.

Organoid lumen formation can provide a useful readout in epithelial models.

Co-culture with immune, stromal or endothelial cells can increase model complexity.

Organoid culture is compatible with transcriptomics, proteomics, metabolomics and other omics approaches.

Organoid nomenclature is evolving, so clear descriptions of cell source and architecture are more useful than labels alone.

Organoids can help study genotype-phenotype relationships in human tissue contexts.

Clonal organoids can help study cell-intrinsic differences between individual stem or tumour cells.

Organoids can contain multiple differentiated cell types from the same tissue lineage.

Polarity can sometimes be reversed or altered to make specific surfaces more experimentally accessible.

A spheroid is not necessarily an organoid; spheroids can be simple aggregates without organ-like organisation.

Organoids can be used to model recovery and regeneration after injury-like perturbations.

Organoid research often benefits from reporting both successful and failed differentiation outcomes.

Organoids can be expanded from small starting samples when the relevant stem or progenitor cells are maintained.

Organoid-on-chip systems combine 3D tissue organisation with engineered control of the microenvironment.

Time-lapse imaging can reveal dynamic phenotypes that are missed by endpoint measurements.

Automated liquid handling can reduce operator variability in organoid workflows.

Organoids can reveal heterogeneity within a patient's disease that may not be obvious from bulk tissue measurements.

Cell death within an organoid can be spatially patterned rather than uniform.

Some organoids maintain long-lived stem-cell compartments that support repeated passaging.

Matrix composition can affect polarity, branching, invasion and lineage commitment.

Culture conditions can select for certain cell populations and under-represent others.

Organoid cultures can contain non-target cell types, especially during pluripotent stem cell differentiation.

Organoids are not automatically better than simpler models; the best model depends on the scientific question.

Off-target cell populations may be unwanted noise or useful clues about developmental signalling.

Organoids can model rare diseases when patient tissue or patient-derived iPSCs are available.

Many organoids arise through self-organisation when stem or progenitor cells receive appropriate biochemical cues.

Organoid differentiation protocols often mimic developmental signalling pathways used in vivo.

Organoid quality control can include morphology, marker expression, cell composition and functional assays.

Secreted proteins in organoid culture medium can serve as functional or disease-related readouts.

Small changes in protocol timing can shift lineage composition in sensitive differentiation systems.

Organoids can provide human-specific biology that is difficult to study directly in living people.

Organoid models can be used to investigate how tissue architecture changes after genetic perturbation.

Organoid culture can support longitudinal experiments that would be difficult with a single biopsy.

Organoids can be cryopreserved, enabling biobanking and repeated experiments from related material.

iPSC-derived organoids can capture a donor's genome while allowing differentiation into tissues that are difficult to biopsy.

Donor-derived intestinal models can reveal person-to-person differences in inflammation.

Disease-relevant perturbations can be introduced to test how intestinal models respond through host-microbe interactions.

A fit-for-purpose intestinal model may prioritise epithelial barrier function over anatomical completeness.

Epithelial barrier function is one reason intestinal organoids or chips are useful beyond conventional monolayer culture.

Host-microbe interactions is one reason intestinal organoids or chips are useful beyond conventional monolayer culture.

Donor-derived intestinal models can reveal person-to-person differences in nutrient transport.

Intestinal organoid and chip models can be used to study mucus production.

Disease-relevant perturbations can be introduced to test how intestinal models respond through inflammation.

Adding flow, co-culture or matrix cues can change how a intestinal model reproduces inflammation.

Researchers use intestinal models to investigate intestinal stem-cell renewal in a human-relevant in vitro setting.

Disease-relevant perturbations can be introduced to test how intestinal models respond through intestinal stem-cell renewal.

Donor-derived intestinal models can reveal person-to-person differences in host-microbe interactions.

A fit-for-purpose intestinal model may prioritise nutrient transport over anatomical completeness.

Adding flow, co-culture or matrix cues can change how a intestinal model reproduces nutrient transport.

Intestinal organoid and chip models can be used to study host-microbe interactions.

A fit-for-purpose intestinal model may prioritise intestinal stem-cell renewal over anatomical completeness.

A fit-for-purpose intestinal model may prioritise mucus production over anatomical completeness.

Researchers use intestinal models to investigate mucus production in a human-relevant in vitro setting.

Researchers use intestinal models to investigate inflammation in a human-relevant in vitro setting.

Donor-derived intestinal models can reveal person-to-person differences in mucus production.

Time-course measurements can show whether changes in epithelial barrier function are transient or sustained in intestinal models.

Disease-relevant perturbations can be introduced to test how intestinal models respond through epithelial barrier function.

Donor-derived intestinal models can reveal person-to-person differences in epithelial barrier function.

In intestinal models, inflammation can be measured alongside cell morphology and viability.

In intestinal models, intestinal stem-cell renewal can be measured alongside cell morphology and viability.

Time-course measurements can show whether changes in nutrient transport are transient or sustained in intestinal models.

Disease-relevant perturbations can be introduced to test how intestinal models respond through mucus production.

In intestinal models, mucus production can be measured alongside cell morphology and viability.

Benchmarking mucus production against primary tissue improves confidence in a intestinal model.

A fit-for-purpose intestinal model may prioritise host-microbe interactions over anatomical completeness.

In intestinal models, nutrient transport can be measured alongside cell morphology and viability.

Nutrient transport is one reason intestinal organoids or chips are useful beyond conventional monolayer culture.

Donor-derived intestinal models can reveal person-to-person differences in intestinal stem-cell renewal.

Researchers use intestinal models to investigate host-microbe interactions in a human-relevant in vitro setting.

In intestinal models, host-microbe interactions can be measured alongside cell morphology and viability.

Time-course measurements can show whether changes in intestinal stem-cell renewal are transient or sustained in intestinal models.

A fit-for-purpose intestinal model may prioritise inflammation over anatomical completeness.

Researchers use intestinal models to investigate nutrient transport in a human-relevant in vitro setting.

Adding flow, co-culture or matrix cues can change how a intestinal model reproduces host-microbe interactions.

Intestinal organoid and chip models can be used to study nutrient transport.

Inflammation is one reason intestinal organoids or chips are useful beyond conventional monolayer culture.

Disease-relevant perturbations can be introduced to test how intestinal models respond through nutrient transport.

Time-course measurements can show whether changes in inflammation are transient or sustained in intestinal models.

Time-course measurements can show whether changes in host-microbe interactions are transient or sustained in intestinal models.

Intestinal organoid and chip models can be used to study intestinal stem-cell renewal.

Mucus production is one reason intestinal organoids or chips are useful beyond conventional monolayer culture.

Benchmarking nutrient transport against primary tissue improves confidence in a intestinal model.

Benchmarking intestinal stem-cell renewal against primary tissue improves confidence in a intestinal model.

Adding flow, co-culture or matrix cues can change how a intestinal model reproduces mucus production.

Benchmarking host-microbe interactions against primary tissue improves confidence in a intestinal model.

Time-course measurements can show whether changes in mucus production are transient or sustained in intestinal models.

Researchers use intestinal models to investigate epithelial barrier function in a human-relevant in vitro setting.

Benchmarking epithelial barrier function against primary tissue improves confidence in a intestinal model.

Intestinal organoid and chip models can be used to study inflammation.

Adding flow, co-culture or matrix cues can change how a intestinal model reproduces intestinal stem-cell renewal.

Adding flow, co-culture or matrix cues can change how a intestinal model reproduces epithelial barrier function.

Benchmarking inflammation against primary tissue improves confidence in a intestinal model.

In intestinal models, epithelial barrier function can be measured alongside cell morphology and viability.

Intestinal organoid and chip models can be used to study epithelial barrier function.

Intestinal stem-cell renewal is one reason intestinal organoids or chips are useful beyond conventional monolayer culture.

A fit-for-purpose tissue model may prioritise matrix remodelling over anatomical completeness.

Regeneration is one reason tissue organoids or chips are useful beyond conventional monolayer culture.

Benchmarking wound repair against primary tissue improves confidence in a tissue model.

Benchmarking matrix remodelling against primary tissue improves confidence in a tissue model.

Researchers use tissue models to investigate barrier formation in a human-relevant in vitro setting.

Researchers use tissue models to investigate wound repair in a human-relevant in vitro setting.

Time-course measurements can show whether changes in barrier formation are transient or sustained in tissue models.

Matrix remodelling is one reason tissue organoids or chips are useful beyond conventional monolayer culture.

Donor-derived tissue models can reveal person-to-person differences in mechanical loading.

Adding flow, co-culture or matrix cues can change how a tissue model reproduces regeneration.

Donor-derived tissue models can reveal person-to-person differences in matrix remodelling.

Disease-relevant perturbations can be introduced to test how tissue models respond through regeneration.

Disease-relevant perturbations can be introduced to test how tissue models respond through matrix remodelling.

Benchmarking mechanical loading against primary tissue improves confidence in a tissue model.

Time-course measurements can show whether changes in matrix remodelling are transient or sustained in tissue models.

A fit-for-purpose tissue model may prioritise barrier formation over anatomical completeness.

A fit-for-purpose tissue model may prioritise regeneration over anatomical completeness.

Tissue organoid and chip models can be used to study regeneration.

Donor-derived tissue models can reveal person-to-person differences in wound repair.

Adding flow, co-culture or matrix cues can change how a tissue model reproduces mechanical loading.

Time-course measurements can show whether changes in mechanical loading are transient or sustained in tissue models.

In tissue models, matrix remodelling can be measured alongside cell morphology and viability.

Time-course measurements can show whether changes in regeneration are transient or sustained in tissue models.

Adding flow, co-culture or matrix cues can change how a tissue model reproduces barrier formation.

Disease-relevant perturbations can be introduced to test how tissue models respond through barrier formation.

A fit-for-purpose tissue model may prioritise mechanical loading over anatomical completeness.

Benchmarking regeneration against primary tissue improves confidence in a tissue model.

Benchmarking barrier formation against primary tissue improves confidence in a tissue model.

Researchers use tissue models to investigate regeneration in a human-relevant in vitro setting.

Adding flow, co-culture or matrix cues can change how a tissue model reproduces wound repair.

In tissue models, regeneration can be measured alongside cell morphology and viability.

Adding flow, co-culture or matrix cues can change how a tissue model reproduces matrix remodelling.

In tissue models, mechanical loading can be measured alongside cell morphology and viability.

Donor-derived tissue models can reveal person-to-person differences in barrier formation.

A fit-for-purpose tissue model may prioritise wound repair over anatomical completeness.

Time-course measurements can show whether changes in wound repair are transient or sustained in tissue models.

Tissue organoid and chip models can be used to study mechanical loading.

Wound repair is one reason tissue organoids or chips are useful beyond conventional monolayer culture.

Researchers use tissue models to investigate matrix remodelling in a human-relevant in vitro setting.

Barrier formation is one reason tissue organoids or chips are useful beyond conventional monolayer culture.

Tissue organoid and chip models can be used to study barrier formation.

Disease-relevant perturbations can be introduced to test how tissue models respond through wound repair.

Researchers use tissue models to investigate mechanical loading in a human-relevant in vitro setting.

In tissue models, wound repair can be measured alongside cell morphology and viability.

Tissue organoid and chip models can be used to study matrix remodelling.

Donor-derived tissue models can reveal person-to-person differences in regeneration.

Tissue organoid and chip models can be used to study wound repair.

Disease-relevant perturbations can be introduced to test how tissue models respond through mechanical loading.

In tissue models, barrier formation can be measured alongside cell morphology and viability.

Mechanical loading is one reason tissue organoids or chips are useful beyond conventional monolayer culture.